Maria Teresa Bilotta

Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay

Maria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda et al. · Journal of Hematology & Oncology · 2016 · 94 citations · Full text

Life Sciences, Immunology, Oncology +17

Granulocytic Myeloid–Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level

Nicola Tumino, Maria Teresa Bilotta, Carmela Pinnetti et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2017 · 30 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Activation of liver X receptor up‐regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms

Maria Teresa Bilotta, Maria Pia Abruzzese, Rosa Molfetta et al. · The FASEB Journal · 2019 · 27 citations

Life Sciences, Immunology, Oncology +15

The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors

Maria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda et al. · Cell Death and Disease · 2019 · 18 citations · Full text

Medicine, Molecular Biology, Oncology +15

Antibody drug conjugates, targeting cancer-expressed EGFR, exhibit potent and specific antitumor activity

Eric Ho, Rong Qiu, Ellis Miller et al. · Biomedicine & Pharmacotherapy · 2022 · 14 citations · Full text

Pharmacy, Oncology, Pharmacology +17